On June 26, 2025, Praxis Precision Medicines, Inc. held its Annual Meeting where stockholders elected two new directors, ratified Ernst & Young as their accounting firm for 2025, and approved executive compensation with various vote results. The meeting saw a quorum present, and the voting details were shared in the report.